How to measure heart rate? C. Ulrich VogelChristian WolpertMartin Wehling Clinical Trials 05 August 2004 Pages: 461 - 466
Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals Valery V. BakayevForozan MohammadiAli A. Velayati Pharmacogenetics 13 August 2004 Pages: 467 - 471
Population pharmacokinetic analysis of mirtazapine Katja GrasmäderPetra Louise VerwohltMarie Luise Rao Pharmacokinetics and Disposition 29 July 2004 Pages: 473 - 480
Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives Ornella BaisiniFederica BeniniAlberto Lanzini Pharmacokinetics and Disposition 28 July 2004 Pages: 481 - 487
Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study Deborah LaytonLynda V. WiltonSaad A. W. Shakir Pharmacoepidemiology and Prescription 22 July 2004 Pages: 489 - 501
Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe T. WalleyP. Folino-GalloP. Stephens Pharmacoepidemiology and Prescription 13 August 2004 Pages: 503 - 511
Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey Lorenza MaglianoAndrea FiorilloThe National Mental Health Project Working Group Pharmacoepidemiology and Prescription 13 August 2004 Pages: 513 - 522
Patterns and correlates of benzodiazepine use in the French general population Rajaa LagnaouiFanny DepontNicholas Moore Pharmacoepidemiology and Prescription 28 August 2004 Pages: 523 - 529